Algorhythm Holdings, Inc. — Form 8-K Summary
Business Context and Reporting Period
The Form 8-K reports events occurring on September 21, 2026, with the filing signed September 22, 2026. The company’s common stock trades on Nasdaq under the symbol RIME.
Key Financial Metrics and Liquidity
- The filing does not provide revenue, earnings, cash flow, margin, cash balance, or total debt metrics.
- The reported liabilities subject to the terminated settlement had an original principal amount of $1,928,014.
- The company estimates that approximately $1,418,649 remains due under those liabilities.
Material Changes Versus the Prior Comparable Period
On September 21, 2026, the company and Continuation Capital, Inc. terminated a July 21, 2026 settlement agreement concerning the outstanding liabilities. The termination ends the company’s further obligation to issue shares under that agreement.
Under the terminated agreement, the company had agreed to issue up to 5,000,000 common shares in one or more tranches until Continuation Capital received aggregate proceeds equal to 120% of the $1,928,014 claim amount. The filing does not state how many shares had been issued before termination or whether the remaining liabilities were otherwise discharged, modified, or refinanced.
Guidance, Outlook, Risks, and Unusual Items
On September 22, 2026, the company updated its corporate presentation for investor meetings and website publication. The presentation contains forward-looking statements regarding the company’s expectations, plans, and potential results.
Management cautioned that actual results may differ materially because of risks, uncertainties, and assumptions described in the company’s SEC filings, including its Form 10-K for the year ended December 31, 2025. The company disclaimed any obligation to update forward-looking statements except as required by law.
Important Facts for Investors to Verify
- Confirm the number of shares, if any, issued to Continuation Capital before the settlement termination.
- Determine how the approximately $1.42 million remaining liability will be settled and its expected effect on liquidity and capital structure.
- Review the updated investor presentation and distinguish its forward-looking statements from historical information.
- Review the company’s Form 10-K for 2025 and subsequent SEC filings for additional liquidity, financing, dilution, and liability disclosures.